Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, novembre 21
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Insmed Inc
INSM
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$141.33
-3.13
-2.17%
À la clôture: Nov 20, 4:00 PM EST
$142.81
1.48
1.05%
Après les heures: 7:09 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Insmed Financials
Insmed (INSM) financial statements — income, revenue, gross margin and key metrics.
PRO
Pourquoi cela bouge-t-il ?:
Insmed shares are trading higher after reports suggesting that Sanofi is co...
Earnings & Guidance News
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
Anthropic opened 34% above its $83 IPO price, but the S&P 500 and Dow fell as health insurers and Walmart slid.
Piero Cingari
Alphabet Sinks 11.8%, Small Caps Rally on Strong GDP Growth: Stock Market Today
Alphabet's capex-heavy quarter drags the Nasdaq 100 lower while GDP beats and the Russell 2000 rallies, with three of four large caps rising.
Piero Cingari
PRO
Insmed Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $524.428M Beat $501.350M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 73.71 percent increase over losses of $(1.75) per share from the same
Benzinga Newsdesk
PRO
Insmed Raises FY2026 Sales Guidance from $1.700B-$1.870B to $1.810B-$1.870B vs $1.801B Est
Insmed (NASDAQ:INSM) raises FY2026 sales outlook from $1.700 billion-$1.870 billion to $1.810 billion-$1.870 billion vs $1.801 billion estimate.
Benzinga Newsdesk
Insmed Stock Slides — CFO Exit Date Set, 2026 Guidance Reaffirmed
Insmed shares slip after CFO Sara Bonstein steps down, reaffirms 2026 financial targets.
Vandana Singh
PRO
Insmed Reaffirms FY26 Revenue Guidance Of $1.25B-$1.40B For BRINSUPRI And $450M- $470M For ARIKAYCE
Reaffirms Full-Year 2026 GuidanceAs Insmed continues to build on its operational excellence and momentum, the Company reaffirms its full-year 2026 financial guidance of revenue in the range of $1.25 billion to $1.40
Benzinga Newsdesk